FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293420161> ?p ?o ?g. }

• W4293420161 abstract "Previous studies have demonstrated that TRIB3 is closely related to insulin resistance, metabolic disorders and vascular diseases. Recently, it was reported that a 33 bp variable number of tandem repeats (VNTR) located in the TRIB3 promoter could considerably alter its transcriptional activity. Nonetheless, whether the shift of TRIB3 transcriptional activity has the effect of inducing diabetic vascular complications is still unclear. Therefore, in our study, we aimed to explore the relationship between the TRIB3 33bp VNTR and diabetic vascular complications. The TRIB3 33bp VNTR polymorphisms were determined by PCR and Sanger sequencing, a total of 798 eligible Chinese patients with type 2 diabetes (T2DM) were included in our study and then evaluated with clinical data. After adjusting for age, gender, BMI, smoking history, drinking history and duration of diabetes, we found that the high number of 33 bp tandem repeats (repeats>8) was significantly associated with an increase in the risk of cerebrovascular diseases compared with the low number of 33 bp tandem repeats (repeats≤6) in patients with T2DM(OR 2.66, 95% CI 1.29-5.47, p = 0.008). The intermediate number of 33bp tandem repeats (6 < repeat≤8) was markedly associated with a decreased risk of diabetic retinopathy compared with the low number of tandem repeats (OR 0.65, 95% CI 0.46-0.91, p = 0.012). Adjusting for gender, age and BMI, there was a significant difference in DBP levels among patients with the number of different 33 bp tandem repeats (Low vs. Intermediate vs. High, 81.6 ± 12.8 vs. 79.8 ± 12.4 vs. 78.7 ± 12.6 mmHg; p = 0.045). Subgroup analysis found that TRIB3 VNTR was significantly correlated with the difference in systolic blood pressure (SBP) in T2DM patients taking ACEI/ARB drugs (Low vs. Intermediate vs. High, 146.27 ± 18.23 vs. 140.01 ± 19.91 vs. 140.77 ± 18.64 mmHg; p = 0.018). Our results indicated that TRIB3 promoter 33bp VNTR is related to vascular diseases in T2DM patients, and may serve as a new biomarker for individualized prevention and therapy of T2DM." @default.
• W4293420161 created "2022-08-29" @default.
• W4293420161 creator A5013653061 @default.
• W4293420161 creator A5025676631 @default.
• W4293420161 creator A5036255881 @default.
• W4293420161 creator A5044400826 @default.
• W4293420161 creator A5045773186 @default.
• W4293420161 creator A5049692788 @default.
• W4293420161 creator A5056441836 @default.
• W4293420161 creator A5062314508 @default.
• W4293420161 creator A5063548954 @default.
• W4293420161 creator A5072861069 @default.
• W4293420161 creator A5077576606 @default.
• W4293420161 creator A5077791798 @default.
• W4293420161 date "2022-08-29" @default.
• W4293420161 modified "2023-10-01" @default.
• W4293420161 title "TRIB3 promoter 33 bp VNTR is associated with the risk of cerebrovascular disease in type 2 diabetic patients" @default.
• W4293420161 cites W1458331036 @default.
• W4293420161 cites W1970384979 @default.
• W4293420161 cites W1973836767 @default.
• W4293420161 cites W1993387593 @default.
• W4293420161 cites W2019407178 @default.
• W4293420161 cites W2055656028 @default.
• W4293420161 cites W2075459447 @default.
• W4293420161 cites W2087138157 @default.
• W4293420161 cites W2095381542 @default.
• W4293420161 cites W2100466447 @default.
• W4293420161 cites W2108928386 @default.
• W4293420161 cites W2145525849 @default.
• W4293420161 cites W2315099033 @default.
• W4293420161 cites W2315573956 @default.
• W4293420161 cites W2324901576 @default.
• W4293420161 cites W2342155058 @default.
• W4293420161 cites W2533116893 @default.
• W4293420161 cites W2586822913 @default.
• W4293420161 cites W2770364170 @default.
• W4293420161 cites W2782071181 @default.
• W4293420161 cites W2887815365 @default.
• W4293420161 cites W2923736308 @default.
• W4293420161 cites W3016032450 @default.
• W4293420161 cites W3038629520 @default.
• W4293420161 cites W3046366630 @default.
• W4293420161 cites W3096046625 @default.
• W4293420161 cites W3097944786 @default.
• W4293420161 cites W3121105072 @default.
• W4293420161 cites W3148294016 @default.
• W4293420161 cites W3163854057 @default.
• W4293420161 cites W3198788663 @default.
• W4293420161 cites W3202998119 @default.
• W4293420161 cites W3209152707 @default.
• W4293420161 cites W4200136038 @default.
• W4293420161 cites W4212925171 @default.
• W4293420161 cites W4239287623 @default.
• W4293420161 doi "https://doi.org/10.3389/fgene.2022.916281" @default.
• W4293420161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36105108" @default.
• W4293420161 hasPublicationYear "2022" @default.
• W4293420161 type Work @default.
• W4293420161 citedByCount "1" @default.
• W4293420161 countsByYear W42934201612023 @default.
• W4293420161 crossrefType "journal-article" @default.
• W4293420161 hasAuthorship W4293420161A5013653061 @default.
• W4293420161 hasAuthorship W4293420161A5025676631 @default.
• W4293420161 hasAuthorship W4293420161A5036255881 @default.
• W4293420161 hasAuthorship W4293420161A5044400826 @default.
• W4293420161 hasAuthorship W4293420161A5045773186 @default.
• W4293420161 hasAuthorship W4293420161A5049692788 @default.
• W4293420161 hasAuthorship W4293420161A5056441836 @default.
• W4293420161 hasAuthorship W4293420161A5062314508 @default.
• W4293420161 hasAuthorship W4293420161A5063548954 @default.
• W4293420161 hasAuthorship W4293420161A5072861069 @default.
• W4293420161 hasAuthorship W4293420161A5077576606 @default.
• W4293420161 hasAuthorship W4293420161A5077791798 @default.
• W4293420161 hasBestOaLocation W42934201611 @default.
• W4293420161 hasConcept C104317684 @default.
• W4293420161 hasConcept C126322002 @default.
• W4293420161 hasConcept C134018914 @default.
• W4293420161 hasConcept C141231307 @default.
• W4293420161 hasConcept C180754005 @default.
• W4293420161 hasConcept C189036908 @default.
• W4293420161 hasConcept C27149982 @default.
• W4293420161 hasConcept C2777180221 @default.
• W4293420161 hasConcept C2781179581 @default.
• W4293420161 hasConcept C29511175 @default.
• W4293420161 hasConcept C3017666073 @default.
• W4293420161 hasConcept C51679486 @default.
• W4293420161 hasConcept C54355233 @default.
• W4293420161 hasConcept C555293320 @default.
• W4293420161 hasConcept C61320498 @default.
• W4293420161 hasConcept C71924100 @default.
• W4293420161 hasConcept C76818968 @default.
• W4293420161 hasConcept C86803240 @default.
• W4293420161 hasConceptScore W4293420161C104317684 @default.
• W4293420161 hasConceptScore W4293420161C126322002 @default.
• W4293420161 hasConceptScore W4293420161C134018914 @default.
• W4293420161 hasConceptScore W4293420161C141231307 @default.
• W4293420161 hasConceptScore W4293420161C180754005 @default.
• W4293420161 hasConceptScore W4293420161C189036908 @default.
• W4293420161 hasConceptScore W4293420161C27149982 @default.
• W4293420161 hasConceptScore W4293420161C2777180221 @default.
• W4293420161 hasConceptScore W4293420161C2781179581 @default.

• next